Table 1.
No. | Initials | Sex | Age, yr | Duration of disease, yr* | EDSS*† | HLA-DR type |
---|---|---|---|---|---|---|
MS 1 | SSt | F | 35 | 9 | 4.0 | 2, 5 |
MS 2 | HK | M | 34 | 8 | 1.0 | 3, 12 |
MS 3 | AZ | M | 28 | 1 | 1.0 | 2, 7 |
MS 4 | HM | F | 25 | 2 | 1.0 | 2 |
MS 5 | SW | F | 40 | 11 | 3.5 | 2, 8 |
MS 6 | CS | F | 42 | 4 | 1.0 | 4, 8 |
MS 7 | GJ | F | 30 | 1 | 1.0 | 4, 6 |
MS 8 | WHa | F | 43 | 1 | 2.5 | 2, 11 |
MS 9 | HC | F | 32 | 2 | 2.5 | 11, 12 |
MS 10 | SZ | F | 34 | 4 | 2.5 | 2, 7 |
MS 11 | LN | F | 36 | 1 | 2.5 | 1, 2 |
MS 12 | BG | F | 33 | 4 | 1.5 | 4, 7 |
MS 13 | UB | F | 39 | 10 | 6.0 | 4, 7 |
MS 14 | US | F | 35 | 2 | 1.0 | 7, 10 |
MS 15 | SH | F | 31 | 3 | 1.0 | 3 |
MS 16 | BS | M | 21 | 1 | 1.5 | 13, 14 |
MS 17 | KR | F | 39 | 4 | 1.5 | 1, 7 |
MS 18 | RD | M | 40 | 17 | 2.5 | 2 |
MS 19 | RM | F | 34 | 7 | 1.5 | 7, 13 |
MS 20 | IB | F | 48 | 20 | 4.0 | 7, 11 |
MS 21 | MB | F | 34 | 1 | 1.0 | 2, 7 |
MS 22 | MC | F | 30 | 3 | 5.0 | 3, 7 |
MS 23 | BK | F | 43 | 5 | 1.0 | 2, 4 |
MS 24 | RR | M | 28 | 2 | 4.0 | 2, 11 |
MS 25 | RO | F | 33 | 2 | 3.5 | 7, 13 |
MS 26 | AF | F | 18 | 2 | 1.0 | 10, 12 |
HD 1 | WH | M | 30 | — | — | 2, 11 |
HD 2 | CH | M | 31 | — | — | 11, 13 |
HD 3 | CB | F | 29 | — | — | 4, 11 |
HD 4 | VV | F | 34 | — | — | 4, 15 |
At the time of first sampling.
EDSS, expanded disability status scale (31).